Brave New World: Guidelines and Treatment Strategies for Sickle Cell Disease
Sickle cell disease (SCD) is an inherited red blood cell disorder that affects approximately 100,000 people in the United States. SCD is characterized by extremely painful, acute pain episodes known as vaso-occlusive crises (VOC). VOC are the primary presenting morbidity of SCD and cause of hospitalization in 95% of cases. Recurrent VOC episodes have a significant, negative impact on health related quality of life and have a greater impact than cumulative organ damage. In 2020, the American Society of Hematology published a novel guideline focused exclusively on the management of acute and chronic pain in SCD. This course evaluates those recommendations for acute pain management of VOC and uses a case based approach to discuss a sensible and balanced strategy for pain and symptom management.
This activity is supported by an educational grant from Novartis.
This activity is provided by Global Education Group.
Target Audience
The educational design of this activity addresses the needs of healthcare providers who treat and manage acute and chronic pain, including Internists, Health System Pharmacists, Nurse Practitioners, Primary Care Physicians, Physician Assistants, Physical Therapists, and Psychologists.
Learning Objectives
After completing this activity, the participant should be better able to:
- Summarize the healthcare disparities in accessing care for patients with Sickle Cell Disease (SCD)
- Describe strategies to effectively manage acute and chronic pain in patients with SCD
- Review the recently published guidelines for SCD treatment and management
- Discuss the newly FDA-approved and emerging treatments for adult and pediatric patients with SCD
- Recognize effective communication techniques when diagnosing, treating, and managing patients with SCD
Additional Information
Attachment | Size |
---|---|
Slides and Disclosures | 2.61 MB |
Michelle Krichbaum
PharmD, BCPP
Neil Miransky
DO
Physician Accreditation Statement
Global Education Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Global Education Group designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
Global Education Group is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
This educational activity for 1.0 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacist Accreditation Statement
Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.
Credit Designation
Global Education Group designates this continuing education activity for 1.0 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number - 0530-0000-21-413-H01-P)
This is a knowledge-based activity.
Nurse Practitioner Continuing Education
Global Education Group is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 110121. This activity is approved for 1.0 contact hour(s) (which includes 0.1 hour(s) of pharmacology).
Physician Assistants
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 1.0 hours of Category 1 credit for completing this program.
For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.
Instructions to Receive Credit
During the period from December 17, 2021, to December 17, 2022 , participants must complete the activity evaluation and obtain a score of 75% or better on the posttest and on the final comprehensive examination. Upon completion, your certificate will be available to print. For questions about receiving certificates, please contact info@painweek.org.
For Pharmacists: Please complete the evaluation instructions above. You must complete the activity in its entirety. Partial credit cannot be awarded. Upon registering and completing the activity evaluation, your transcript information will be sent to the NABP CPE Monitor Service within 4-6 weeks of completing this activity.
Fee & Refund/Cancellation Policy
There is no fee for this educational activity.
Disclosure of Conflicts of Interest
All relevant financial relationships have been mitigated.
The faculty have the following relevant financial relationships with ineligible companies:
Name of Faculty or Presenter | Reported Financial Relationship |
Michelle Krichbaum | Nothing to disclose |
Neil Miransky | Nothing to disclose |
The planners and managers have the following relevant financial relationships with ineligible companies:
Name of Planner or Manager | Reported Financial Relationship |
Rhys Williams, MSN, FNP-C, RN | Nothing to disclose |
Kristin Delisi, NP | Nothing to disclose |
Lindsay Borvansky | Nothing to disclose |
Andrea Funk | Nothing to disclose |
Liddy Knight | Nothing to disclose |
Ashley Cann | Nothing to disclose |
Kimberly Rodriguez | Nothing to disclose |
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) does not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Available Credit
- 1.00 AANP
- 1.00 ACCME (All Other)
- 1.00 ACCME (MD/DO Only)
- 1.00 ACPE Pharmacy
- 0.00 ACPE Technician
- 1.00 ANCC
- 1.00 APA
Required Hardware/software
System Requirements
PC Microsoft Internet Explorer 11 or later, Windows Edge browser, Mozilla Firefox, and Google Chrome For HTML Client – Google Chrome (v70.0 & above), Mozilla Firefox (v65.0 & above), and Edge (v42.0 & above) | MAC Mozilla Firefox, Apple Safari, Google Chrome For HTML Client – Google Chrome (v70.0 & above), Apple Safari (v12.0 & above), and Mozilla Firefox (v65.0 & above) |